Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03142334 |
|---|---|
| Brief Title: | Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564) |
| First Submitted : | May 3, 2017 |
| First Submitted that Met QC Criteria : | May 3, 2017 |
| First Posted : | May 5, 2017 |
| Results First Submitted : | November 29, 2021 |
| Results First Submitted that Met QC Criteria : | November 29, 2021 |
| Results First Posted : | December 28, 2021 |
| Last Update Submitted that Met QC Criteria : | June 28, 2023 |
| Last Update Posted : | June 29, 2023 |